{
    "type": "ETP",
    "ucits": false,
    "replication_method": "physical",
    "leverage": true,
    "derivatives": false,
    "swaps": false,
    "inverse": false,
    "complex_factors": [
        "Leverage",
        "Daily Compounding",
        "Margin Borrowing",
        "High Risk",
        "Sophisticated Investor Targeting"
    ],
    "classification": "complex",
    "supporting_data": "The product is a Collateralised Exchange Traded Security (ETP) designed to provide 3x the daily performance of UBS Group AG equity. It uses physical replication by directly owning the underlying UBS shares and employs margin borrowing to achieve leverage. There is no use of swaps or derivative instruments as part of the replication strategy, and no synthetic replication is mentioned. The product explicitly states a leverage factor of 3x and daily rebalancing, which causes compounding effects that can significantly deviate returns over periods longer than one day. The risk indicator is at the highest level 7/7, indicating very high risk. The product is not UCITS compliant and is targeted at sophisticated investors able to monitor their positions daily. The KIID and factsheet warn about the complexity of daily leveraged returns, compounding effects, and the risk of losing the entire investment. There is no capital protection, and the product is exposed to margin costs and market risk. The absence of derivative usage for replication but presence of leverage and complex daily compounding effects, combined with the product structure as an ETP (debt security) rather than a traditional ETF, drives the classification as complex under MiFID II. The PRIIPs KID also includes a comprehension warning and highlights the need for specific investor knowledge, reinforcing complexity. No swap or derivative counterparty risk disclosures are present, but leverage and compounding effects are the main complexity drivers."
}